SHENZHEN, China, Nov. 23, 2010 /PRNewswire-Asia-FirstCall/ --
Tongjitang Chinese Medicines Company (the "Company"; NYSE: TCM), a
leading specialty pharmaceutical company focusing on the
development, manufacturing, marketing and selling of modernized
traditional Chinese medicine in China, today announced that it plans to
release its third quarter 2010 financial results after market close
on Monday, November 29, 2010.
Tongjitang's management team will hold a conference call on
Tuesday, November 30, at 8:00 a.m. U.S. Eastern Time (9:00 p.m. Beijing/Hong
Kong time) following the announcement. Listeners may access
the call by dialing the following numbers:
|
United States toll free:
|
1-800-391-9278
|
|
|
Hong Kong toll free:
|
800-968-103
|
|
|
Northern China toll free:
|
10 800 712 0046
|
|
|
Southern China toll free:
|
10 800 120 0046
|
|
|
International:
|
1-719-325-2189
|
|
|
|
|
Listeners may access the replay from approximately two hours
after the call ends through December 7,
2010 by dialing the following numbers:
|
United States toll free:
|
1-877-870-5176
|
|
|
International:
|
1-858-384-5517
|
|
|
Password:
|
6958069
|
|
|
|
|
An audio webcast of the call will also be available through the
Company's website at www.tongjitang.com.
About Tongjitang Chinese Medicines Company
Tongjitang Chinese Medicines Company, through its operating
subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution,
Tongjitang Chain Stores, Guizhou Long-Life Pharmaceutical Company
Limited, Qinghai Pulante and Anhui Jingfang, is a vertically
integrated specialty pharmaceutical company focused on the
development, manufacturing, marketing and selling of modernized
traditional Chinese medicine in China. Tongjitang's principal executive
offices are located in Shenzhen,
China.
Tongjitang's flagship product, Xianling Gubao, is the leading
traditional Chinese medicine for the treatment of osteoporosis in
China as measured by sales in
Renminbi. In addition to Xianling Gubao, the Company
manufactures and markets 35 other modernized traditional Chinese
medicine products and 36 western medicines. Please visit
www.tongjitang.com for more information.
|
CONTACT
|
|
|
|
|
ICR, LLC
|
|
|
Ashley M. Ammon or Christine Duan
|
|
|
203-682-8200 (Investor Relations)
|
|
|
|
SOURCE Tongjitang Chinese Medicines Company